News and Announcements
BIG Investor Presentation May 2016
- Published May 11, 2016 5:51PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
10th May 2016, ASX Announcement
Rights Issue – May 2016
Eligible shareholders are now able to subscribe for 1 new share for every 4 existing shares they hold at an issue price of $0.12 per share, together with one free attaching option for every two new share subscribed for with an exercise price of $0.25 and term of 18 months.
The offer price represents a 25.8% discount to the volume weighted average trading price (VWAP) for the 5 days trading to the 6th May 2016.
- 1 for 4 partially underwritten non-renounceable rights issue to raise up to $2.64 million
- Offer underwritten by CPS Capital to $1.3 million
- For every two new shares, shareholders will receive 1 free attaching listing option with excersise price of $0.25 and terms of 18 months
To view the full presentation, please click on the button below.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
